Acclinate
Developer of a digital health platform designed to facilitate an increase in representation and diversity of their genomic research and clinical trials. The company's platform utilizes machine learnin...
Valuation
$40M
Market implied
Share Price
N/A
Total Raised
$12.1M
Last Round
N/A